CCNA2 Recombinant Antibody
Product Specifications
Background
Cyclin which controls both the G1/S and the G2/M transition phases of the cell cycle. Functions through the formation of specific serine/threonine protein kinase holoenzyme complexes with the cyclin-dependent protein kinases CDK1 or CDK2. The cyclin subunit confers the substrate specificity of these complexes and differentially interacts with and activates CDK1 and CDK2 throughout the cell cycle.
Synonyms
Cyclin-A2, Cyclin-A, CCNA2
Gene ID
890
Swiss Prot
P20248
Host
Rabbit
Cross Reactivity
Human
Target
CCNA2
Clonality
Recombinant
Conjugation
Unconjugated
Source
Human Cyclin A2 aa 1-200
Applications
WB, IHC-P, IHC-F, IF, ICC/IF
Purification
Purified by Protein A.
Concentration
Lot dependent
Dilution
WB (1:300-5000), IHC-P (1:200-400), IHC-F (1:100-500), IF (), ICC/IF (1:50-100)
Buffer
0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Modification
Unmodified
Storage Conditions
Store at -20°C for 12 months.
Prediction Reactivity
Mouse, Rat
Gene ID URL
890
Isotype
IgG
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1474524-01 0.02 mg (E-Coli)
Recombinant Vibrio vulnificus Ribonuclease P protein component (rnpA)
Ask
View Details 
MBS1474524-02 0.1 mg (E-Coli)
Recombinant Vibrio vulnificus Ribonuclease P protein component (rnpA)
Ask
View Details MBS1474524-03 0.02 mg (Yeast)
Recombinant Vibrio vulnificus Ribonuclease P protein component (rnpA)
Ask
View Details 
MBS1474524-04 0.1 mg (Yeast)
Recombinant Vibrio vulnificus Ribonuclease P protein component (rnpA)
Ask
View Details MBS1474524-05 0.02 mg (Baculovirus)
Recombinant Vibrio vulnificus Ribonuclease P protein component (rnpA)
Ask
View Details MBS1474524-06 1 mg (E-Coli)
Recombinant Vibrio vulnificus Ribonuclease P protein component (rnpA)
Ask
View Details